These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27578041)

  • 21. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies.
    Chua MLK; Lo W; Pintilie M; Murgic J; Lalonde E; Bhandari V; Mahamud O; Gopalan A; Kweldam CF; van Leenders GJLH; Verhoef EI; Hoogland AM; Livingstone J; Berlin A; Dal Pra A; Meng A; Zhang J; Orain M; Picard V; Hovington H; Bergeron A; Lacombe L; Fradet Y; Têtu B; Reuter VE; Fleshner N; Fraser M; Boutros PC; van der Kwast TH; Bristow RG
    Eur Urol; 2017 Nov; 72(5):665-674. PubMed ID: 28511883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding and circular RNAs in lung cancer: advances and perspectives.
    Xie W; Yuan S; Sun Z; Li Y
    Epigenomics; 2016 Sep; 8(9):1275-87. PubMed ID: 27585562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of gastric cancer.
    Li L; Jia F; Bai P; Liang Y; Sun R; Yuan F; Zhang L; Gao L
    Tumour Biol; 2016 Jan; 37(1):299-303. PubMed ID: 26206497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding RNAs as biomarkers for metastatic prostate cancer.
    Veltri WR
    Lancet Oncol; 2014 Dec; 15(13):1412-1413. PubMed ID: 25456354
    [No Abstract]   [Full Text] [Related]  

  • 25. Long noncoding RNAs and neuroblastoma.
    Pandey GK; Kanduri C
    Oncotarget; 2015 Jul; 6(21):18265-75. PubMed ID: 26087192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
    Hua J; Lu J; Isaev K; Soares F; Guo H; Ahmed M; He HH
    Per Med; 2017 Mar; 14(2):159-169. PubMed ID: 29754555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
    Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
    Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics.
    Shi T; Gao G; Cao Y
    Dis Markers; 2016; 2016():9085195. PubMed ID: 27143813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS.
    Janaththani P; Srinivasan SL; Batra J
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
    Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
    Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk loci, biological candidates and biomarkers.
    Nat Genet; 2008 Mar; 40(3):257. PubMed ID: 18305468
    [No Abstract]   [Full Text] [Related]  

  • 32. Seminal fluid: a useful source of prostate cancer biomarkers?
    Roberts MJ; Richards RS; Gardiner RA; Selth LA
    Biomark Med; 2015; 9(2):77-80. PubMed ID: 25689895
    [No Abstract]   [Full Text] [Related]  

  • 33. New Genetic Markers for Prostate Cancer.
    Leapman MS; Carroll PR
    Urol Clin North Am; 2016 Feb; 43(1):7-15. PubMed ID: 26614025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of long non-coding RNA GLIDR in prostate cancer.
    Zhang Y; Kong Z; Zhang Y; Huang W; Wu H; Wan X; Li Y
    Cancer Biomark; 2017; 19(2):145-150. PubMed ID: 28211799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Going viral? Linking the etiology of human prostate cancer to the
    Teixeira AA; Marchiò S; Dias-Neto E; Nunes DN; da Silva IT; Chackerian B; Barry M; Lauer RC; Giordano RJ; Sidman RL; Wheeler CM; Cavenee WK; Pasqualini R; Arap W
    EMBO Mol Med; 2017 Oct; 9(10):1327-1330. PubMed ID: 28751581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients.
    Zhao R; Sun F; Bei X; Wang X; Zhu Y; Jiang C; Zhao F; Han B; Xia S
    Prostate; 2017 Jul; 77(10):1107-1117. PubMed ID: 28585762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bright side of dark matter: lncRNAs in cancer.
    Evans JR; Feng FY; Chinnaiyan AM
    J Clin Invest; 2016 Aug; 126(8):2775-82. PubMed ID: 27479746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer.
    Liu Y; Zhang R; Zhao N; Zhang Q; Yan Z; Chang Z; Wei Y; Wu C; Xu J; Xu Y
    Mol Biosyst; 2016 Oct; 12(10):3176-85. PubMed ID: 27507663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
    Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
    Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.